Spectrum Pharmaceuticals
Search results
- Open0.3300High0.3395Low0.3230
- Mkt Cap411.92MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close0.329952 Wk. Low0.290052 Wk. High1.0900
Related stocks
Open | 0.3300 |
High | 0.3395 |
Low | 0.3230 |
Mkt Cap | 411.92M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 0.3299 |
52 Wk. Low | 0.2900 |
52 Wk. High | 1.0900 |
Related stocks
Development-stage American pharmaceutical company
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 510k | 153.70% ▲ |
Net Income | -17.87M | - |
Diluted EPS | - |
S&P FuturesES=F | 5,636.00+6.25 (+0.11%) |
Dow FuturesYM=F | 41,480.00+53.00 (+0.13%) |
Nasdaq FuturesNQ=F | 19,539.75+9.50 (+0.05%) |
Bitcoin USDBTC-USD | 59,029.43-1.78% |
32.52+3.73% | |
Ethereum USDETH-USD | 2,323.97-3.81% |